Navigation Links
Insmed Announces First Quarter 2008 Financial Results

speak only as of the date of this release. We undertake no obligation to publicly release the results of any revisions to these forward-looking statements that may be made to reflect events or circumstances that occur after the date of this release or to reflect the occurrence of unanticipated events.

Investor Relations Contact:

Brian Ritchie - FD


Corporate Communications Contact:

John Procter - Gibraltar Associates



Consolidated Balance Sheets

(in thousands, except share and per share data)


March 31, December 31,

2008 2007


Current assets:

Cash, cash equivalents and short-term

investments $12,030 $16,479

Accounts receivable, net 327 250

Prepaid expenses 110 244

Total current assets 12,467 16,973

Long-term assets:

Restricted cash - long term 2,095 2,095

Investments 108 258

Deferred financing costs, net 142 170

Property and equipment, net - 4

Total long-term assets 2,345 2,527

Total assets $14,812 $19,500

Liabilities and stockholders' equity

Current liabilities:

Accounts payable $804 $904

SOURCE Insmed Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Insmed Appoints Dennis M. Lanfear to Board Of Directors
2. Insmed Awarded $2.1 Million by Muscular Dystrophy Association
3. Insmed to Appeal Delisting Notification From Nasdaq
4. Insmed President Interviewed for Follow-On Biologics Podcast: Insmed Inc. President Steve Glover Discusses Safe and Effective Biologic Therapies and Reduced Costs with The American Magazine
5. Insmed CEO Issues Statement on White House FY09 Budget and FDA Statements on Follow-On Biologics
6. Insmed to Host Fourth Quarter and Full-Year 2007 Conference Call
7. Insmed Announces Listing Transfer from Nasdaq Global Market to Nasdaq Capital Market
8. Insmed Announces Fourth Quarter and Full-Year 2007 Financial Results
9. Insmed Announces Additional Information in Compliance With NASDAQ Rules
10. Insmed Selected to Complete Congressional Questionnaire Regarding the Potential Establishment of a Follow-On Biologics Regulatory Pathway
11. Insmed to Present at CBI Follow-On Biologics Conference
Post Your Comments:
(Date:10/20/2014)... Richardson, Texas (PRWEB) October 20, 2014 ... today announced that a team from Iowa State University ... * design contest. Using a Convey HC-2ex, the team’s ... than 14 times faster than the second place finisher. ... academic world embarked upon the month long challenge, using ...
(Date:10/20/2014)... Oct. 20, 2014  GenVec, Inc. (NASDAQ: GNVC ... , Ph.D., from its board of directors effective on October ... 2003, and served as its chairman from June 2006 to ... Nominating and Corporate Governance and Audit Committees of the board.  ... a decade of dedicated service to GenVec, and its stockholders," ...
(Date:10/20/2014)... 2014 Local veterinary surgeon, Dr. Tim ... study of donor stem cells for dogs with osteoarthritis. ... and has performed clinical stem cell therapy for 7 ... determine if a single injection of donor stem cells ... reduce pain and inflammation in the treated joints. ...
(Date:10/19/2014)... The Asia-Pacific Bromine Market report defines ... analysis and forecast of revenue. , Browse through ... report, to get an idea of the in-depth ... the segmentation in the Asia-Pacific bromine market, and ... , , Bromine is a ...
Breaking Biology Technology:Team from Iowa State Wins 2014 MemoCODE Design Contest Using Convey HC-2ex 2Team from Iowa State Wins 2014 MemoCODE Design Contest Using Convey HC-2ex 3Zola P. Horovitz To Retire From GenVec Board 2Cascade Veterinary Referral Center Seeks Candidates for an Investigational Study of Stem Cells for Dogs with Arthritis 2The Asia-Pacific Bromine Market is estimated to grow to $4,080.1 million by 2018 - New Report by MicroMarket Monitor 2The Asia-Pacific Bromine Market is estimated to grow to $4,080.1 million by 2018 - New Report by MicroMarket Monitor 3
... (OTC Bulletin Board: BNET) announced that notification was received,today ... System" has been granted by the Commonwealth of Australia,Patent ... The,official filing date is approved as November 8, 2001 ... date of November 8, 2021., This patent now ...
... N.J., Sept. 25 Osteotech, Inc.,(Nasdaq: OSTE ), ... for,regenerative medicine, announced today the appointment of Cato T.,Laurencin, ... joined the,Board of Directors effective September 24, 2008 and ... of the Board of Directors., Kenneth P. Fallon, ...
... Vanda,Pharmaceuticals Inc. (Nasdaq: VNDA ), a ... of clinical-stage product candidates,for central nervous system ... of Vanda Pharmaceuticals Inc. (the "Company") declared ... Right (a "Right") on each,outstanding share of ...
Cached Biology Technology:Bion Announces Approval of New Australian Patent for Low Oxygen Organic Waste Bioconversion for Livestock Waste Environmental Treatment 2Cato T. Laurencin, M.D., Ph.D. to Join Osteotech Board of Directors 2Vanda Pharmaceuticals Declares Dividend Distribution of Preferred Stock Purchase Rights 2Vanda Pharmaceuticals Declares Dividend Distribution of Preferred Stock Purchase Rights 3
(Date:10/18/2014)... Berlin, 19th October 2014 Psychological stress and stress-related ... for aging-related diseases, but the molecular mechanisms ... mechanisms may contribute to the development of ... treatments for these devastating diseases. This work ... Neuropsychopharmacology congress in Berlin., Now an international ...
(Date:10/17/2014)... of Copenhagen have shown for the first time how ... fibrosis patients, giving them the opportunity to get tremendous ... , The study also discovered the bacterial growth in ... halted or slowed down by the immune cells. The ... and helped "suffocate" the bacteria, forcing the bacteria to ...
(Date:10/16/2014)... how the bowel lining develops and, in the process, ... , The researchers produced evidence that stem cells are ... a feature of the bowel lining, and believe these ... controversial finding as scientists are still divided on the ... Chin Wee Tan and Professor Tony Burgess from the ...
Breaking Biology News(10 mins):Researchers find why depression and aging linked to increased disease risk 2Scientists opens black box on bacterial growth in cystic fibrosis lung infection 2Cryptic clues drive new theory of bowel cancer development 2
... Plant Science Center (PSC) have clarified a key epigenetic ... Arabidopsis protects cells from harmful DNA elements. Published in ... Genetics , the finding contributes to advancing our understanding ... plants and animals, opening the door to applications in ...
... Professor Cyrus Cooper, Professor of Rheumatology and Director ... has been awarded the Heberden Medal of the British ... Musculoskeletal Research Programme at the University of Southampton for ... 2003. His research programme has focused on ...
... WASHINGTONA bill in Oregon that would provide incentives to deliver ... the state,s residents and, at the same time, create hundreds ... according to a study released by Upstream Public Health in ... Health Impact Project, a collaboration of the Robert Wood Johnson ...
Cached Biology News:Discovery of DNA silencing mechanism reveals how plants protect their genome 2Oregon Farm to School bill would benefit health through job creation, study finds 2Oregon Farm to School bill would benefit health through job creation, study finds 3
... positive control for ChIP assays. Efficient fixation ... is a crucial step for the Chromatin-immunoprecipitation ... probably the most important parameter. Two major ... be taken into account: first, an excess ...
Mouse monoclonal [M2II-12] to MRP2 ( Abpromise for all tested applications). entrezGeneID: 1244 SwissProtID: Q92887...
The Programmable MP-5000P-F Power Supply can be applied for any Microfluidic application....
Rab GDP dissociation inhibitor beta...
Biology Products: